CORT icon

Corcept Therapeutics

205 hedge funds and large institutions have $1.08B invested in Corcept Therapeutics in 2019 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 70 increasing their positions, 66 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

6% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 66

10% less capital invested

Capital invested by funds: $1.2B → $1.08B (-$126M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
205
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$10.2M
Puts
$5.98M
Net Calls
Net Calls Change

Top Buyers

1 +$17.1M
2 +$15.1M
3 +$7.61M
4
WG
Winton Group
United Kingdom
+$7.2M
5
Invesco
Invesco
Georgia
+$6.47M

Top Sellers

1 -$11M
2 -$8.44M
3 -$4.44M
4
Stifel Financial
Stifel Financial
Missouri
-$3.33M
5
Millennium Management
Millennium Management
New York
-$2.96M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$851K
77
$845K
78
$843K
79
$837K
80
$830K
81
$825K
82
$814K
83
$807K
84
$803K
85
$781K
86
$760K
87
$748K
88
$703K
89
$700K
90
$697K
91
$658K
92
$650K
93
$646K
94
$632K
95
$627K
96
$605K
97
$587K
98
$583K
99
$565K
100
$556K